WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research.

Slenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, Mélius J, Cirillo E, Coort SL, Digles D, Ehrhart F, Giesbertz P, Kalafati M, Martens M, Miller R, Nishida K, Rieswijk L, Waagmeester A, Eijssen LMT, Evelo CT, Pico AR, Willighagen EL. · 2018

Read WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. by Slenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, Mélius J, Cirillo E, Coort SL, Digles D, Ehrhart F, Giesbertz P, Kalafati M, Martens M, Miller R, Nishida K, Rieswijk L, Waagmeester A, Eijssen LMT, Evelo CT, Pico AR, Willighagen EL. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5753270.txt.

Introduction

Slenter and co-authors report updates to WikiPathways, an open database of biological pathways. The platform gathers pathway knowledge in curated, machine readable form. Anyone can add to it, in a wiki style. It feeds analysis and display of omics data across many fields.

Recent curation doubled the number of annotated metabolite nodes. That closes a gap, since genes and proteins once got most attention. The team added OpenAPI records for its web services. FAIR notes were added to raise reuse of the data. New search options, monthly downloads, and portals round out the update.

Catalog record

CREATORSlenter DN, Kutmon M, Hanspers K, Riutta A, Windsor J, Nunes N, Mélius J, Cirillo E, Coort SL, Digles D, Ehrhart F, Giesbertz P, Kalafati M, Martens M, Miller R, Nishida K, Rieswijk L, Waagmeester A, Eijssen LMT, Evelo CT, Pico AR, Willighagen EL.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5753270

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research By Denise N Slenter, Martina Kutmon, Kristina Hanspers, Anders Riutta, Jacob Windsor, Nuno Nunes, Jonathan Mélius, Elisa Cirillo, Susan L Coort, Daniela Digles, Friederike Ehrhart, Pieter Giesbertz Published in: Nucleic Acids Research DOI: 10.1093/nar/gkx1064 ABSTRACT Abstract WikiPathways (wikipathways.org) captures the collective knowledge represented in biological pathways. By providing a database in a curated, machine readable way, omics data analysis and visualization is enabled. WikiPathways and other pathway databases are used to analyze experimental data by research groups in many fields. Due to the open and collaborative nature of the WikiPathways platform, our content keeps growing and is getting more accurate, making WikiPathways a reliable and rich pathway database. Previously, however, the focus was primarily on genes and proteins, leaving many metabolites with only limited annotation. Recent curation efforts focused on improving the annotation of metabolism and metabolic pathways by associating unmapped metabolites with database identifiers and providing more detailed interaction knowledge. Here, we report the outcomes of the continued growth and curation efforts, such as a doubling of the number of annotated metabolite nodes in WikiPathways. Furthermore, we introduce an OpenAPI documentation of our web services and the FAIR (Findable, Accessible, Interoperable and Reusable) annotation of resources to increase the interoperability of the knowledge encoded in these pathways and experimental omics data. New search options, monthly downloads, more links to metabolite databases, and new portals make pathway knowledge more effortlessly accessible to individual researchers and research communities. INTRODUCTION The WikiPathways initiative (wikipathways.org) started in 2008, creating a platform where pathway curation could be performed by means of crowd sourcing (1). The platform’s knowledge-base supports many life sciences communities, ranging from plant biology (2) to drug discovery (3). The use of pathway knowledge in the life sciences is wide-spread, supported by many databases (4–6) as well as integrative resources (7,8). WikiPathways has been used to analyze and integrate experimental transcriptomics, proteomics, and metabolomics data (9–12). Our previous update reported over 2300 pathways for 25 different species (13) and over the last two years this number has increased by 14% to 2614 pathways, as of September 2017. Through pathway curation and the addition of new pathways, human gene coverage present in at least one of our pathways has increased from 30% (7600) to ∼50% (11 532) of all unique human protein-coding genes, see Figure 1. [Figure: Overview of coverage of various gene spaces. WikiPathways (WP) currently covers 11 532 unique human genes. Venn diagram A shows that 50% of the protein coding genes (Ensembl: 22 376 genes) are found in WikiPathways. B shows the 66% coverage of all disease genes (OMIM: 15,262 genes), which also illustrates that the vast majority of genes in WikiPathways are associated with a disease. The C diagram shows that WikiPathways covers 71% of all genes known to be involved in human metabolism (GO metabolic process: 11 296 genes).] The WikiPathways database is improved by continuous data curation and updates through an expanding community: 634 individual contributors to date and 2850 edits on 1060 pathways between August 2016 to August 2017. The availability of all data under a liberal license (wikipathways.org/license) ensures that all contributors benefit from the collective effort of the full WikiPathways community. Similar to the pathway data, the code base is open source and associated formats and ontologies conform to open standards, allowing other developers to participate and join the team (github.com/wikipathways). Pathways are encoded in GPML format and created with PathVisio (14). Genes, proteins and metabolites are linked to other databases with the BridgeDb web service (15). All components are freely available, developed in open collaborations and distributed as open source or open access products. This paper describes our efforts to increase the knowledge covered by biological pathways, with a focus on metabolites, and the usability of WikiPathways in general. These efforts include a more accurate annotation of chemical identities of metabolites, their enzymatic conversions, and protein interactions. This work was triggered by the coming of age of the metabolomics field (16), resulting in a growing amount of experimental data (17). The following sections describe our work of the past two years, organized as updates for biologists and chemists, updates for contributors and curators, and updates for bioinformaticians and data scientists. UPDATES FOR BIOLOGISTS AND CHEMISTS To quantify the results of our curation efforts regarding the growth in metabolite data, the numbers of annotated human metabolites over the past years are shown in Figure 2. Comparing the last five years, the total number of annotated unique metabolite nodes follow a positive trend, having grown by 158% from 1213 in 2013 to 3133 in 2017. The total number of unique metabolites was estimated by counting the unique number of identifiers: all metabolite annotations were first normalized to Wikidata identifiers (18), second to ChEBI (19), third to HMDB (20), in that order, when the normalization to Wikidata was not possible. If none of these three databases provided an identifier for the listed compound, we refer to the metabolite identifier as unmapped. Importantly, the percentage of human metabolites without annotation for the full set of pathways decreased from 5% to 1% over the last five years. [Figure: Metabolite coverage growth in WikiPathways. Taking KEGG as the standard, we plot the growth of WikiPathways (WP) coverage over the past five years. WikiPathways and KEGG unique human metabolite counts were calculated by extracting identifiers from archived WikiPathways releases and unifying to, ideally, Wikidata ID, otherwise ChEBI or HMDB. About two-third of all identifiers (blue line) could be mapped to a Wikidata (red line). Metabolite IDs that could not be mapped to these three databases, have decreased over the last five years (unmapped, green line).] Last year’s growth can partly be explained by the addition of large metabolic pathways as new content, such as the Biochemical Pathways map (Giesbertz, P., Willighagen, E. and Slenter, D. (2017) Biochemical Pathways Part I (Homo sapiens). wikipathways.org/instance/WP3604_r94542). Reactome pathways have been updated to version 61 using an extended version of the previously reported Reactome2GPML converter (21). This converter adds comments to pathway descriptions stating the original Reactome pathway ID, version, and author list. Additionally, a considerable contribution to the growth comprises improved annotation and curation efforts. We improved the biological annotation of several small carbohydrates for multiple Homo sapiens pathways, such as the Glycolysis and Gluconeogenesis pathway (Username:Kdahlquist, Coort, S., Fidelman, N., van Iersel, M., Hanspers, K., Kelder, T., Bouwman, J., Pico, A., Willighagen, E., Kutmon, M., et al. (2017) Glycolysis and Gluconeogenesis (H. sapiens). wikipathways.org/instance/WP534_r94762). We now discriminate between the straight-chain (open) and cyclic (closed) forms of glucose-6-phosphate and fructose-6-phosphate and their conversions into one another. We hope that this and future work on carbohydrates in our pathways will result in a better visualization of data from the glycomics field. In order to let WikiPathways tell the full biological story of a pathway, all elements need to be specified as a gene, protein, metabolite, or pathway node, and associated with an identifier. Further curation work was aimed at improving the annotation of pathways, e.g. by annotating interactions in pathways with their directionality information, such as the direction of enzymatic reactions and the involved enzyme(s). Part of the growth, therefore, is due to

Read the complete text